A new analysis found that eating both oily fish and wholemeal/wholegrain bread may help lower one's risk of developing ...

Sanofi will not be pursuing approval of tolebrutinib for PPMS, and an FDA decision on the therapy in nonrelapsing SPMS will ...

Having multiple sclerosis taught columnist Ahna Crum how to disappear, but she's finding reasons now to let herself be seen and known.

As she prepares to change medications for her MS, columnist Leigh Anne Nelson explores the U.S. government’s registry on ...

Children with MS who have more paramagnetic rim lesions, or chronic inflammation, tend to show faster declines in brain ...

Disease-modifying therapies for MS that prevent brain volume loss are linked to reduced long-term disability, new data show.

Multiple Sclerosis Awareness Month highlights education, advocacy, research support, and ways to uplift the MS community throughout March.

Columnist Susan Payrovi credits hand weakness and MS with the pivots in her medical career that now allow her to focus on ...

Gadoquatrane showed pediatric safety and pharmacokinetic profiles similar to adults in a study, supporting use as a low-dose ...

Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...

Thousands of people from dozens of countries came together in Barcelona this year for Patient Community Day 2025 at the ...

Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...